Comparison of the effect of vitamin D supplementation and metformin on symptoms of polycystic ovary syndrome
DOI:
https://doi.org/10.33448/rsd-v11i7.29950Keywords:
Polycystic Ovarian Syndrome; Metformin; D vitamin.Abstract
Introduction: Polycystic ovary syndrome (PCOS) is characterized as an endocrine, reproductive and metabolic disease, it is a complex and heterogeneous disorder with a prevalence of 5 to 10% in women of reproductive age. Objective: This study aims to evaluate the effect of vitamin D supplementation compared to the use of the drug metformin on the symptoms of Polycystic Ovary Syndrome. Methodology: This research is characterized as descriptive. Results and Discussion: Metformin is a medication widely used in the treatment of PCOS symptoms. Vitamin D, on the other hand, is a pro-hormone well known for its calcium and phosphorus homeostasis function. Conclusion: There was a benefit in both approaches, however, there are differences in terms of side effects and the number of studies to prove efficacy.
References
Albergariab-H. (2017). Ações da vitamina D no metabolismo ósseo e no risco de fratura. In: A importância da vitamina D na saúde da mulher. São Paulo: Federação Brasileira das Associações de Ginecologia e Obstetrícia; 3, 19-27. (Série Orientações e Recomendações FEBRASGO; no. 14/Comissão Nacional Especializada em Osteoporose.
An Androgen Excess Society Guideline. Position Statement. (206). Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome. J Clin Endocrinol Metab, 11(91), 4237-4245,
Angonese, N. T. (2011). Ensaio clínico randomizado com uso de cloridrato de metformina nas doses de 1500mg e 1000mg dia em pacientes com síndrome de ovários policísticos. Universidade Federal Do Paraná. Curitiba, 82.
Araújo, S. M. F. de. (2019). Avaliação dos níveis séricos de vitamina D e fatores associados à Sindrome dos Ovários Policísticos. 2019. Dissertação de Mestrado. Brasil.
Arie, W. M. Y., Fonseca, A. M. D., Bagmoli, V. R., Fassolas, G., & Baracat, E. C. (2009). Síndrome do ovário policístico e metformina: revisão baseada em evidências. Femina.
Azziz, R. (2006). Diagnosis of Polycystic Ovarian Syndrome: The Rotterdam Criteria Are Premature. The Journal of Clinical Endocrinology & Metabolism, 3(91), 781– 785.
Azziz, R. et al. (2004). The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population. The Journal of Clinical Endocrinology & Metabolism, 6(89), 2745–2749.
Baccaro, L. F. C. (20017). Prevalência Da Deficiência De Vitamina D. Federação Brasileira das Associações de Ginecologia e Obstetrícia, São Paulo, 10-18.
Barral, D., Barros, A. C., & De Araújo, R.P. C. (2007). Vitamina D: uma abordagem molecular. Pesquisa Brasileira em Odontopediatria e Clínica Integrada, 7(3), 309-315.
Baskind, N. E., Balen, A. H. (2016). Hypothalamic-pituitary, ovarian and adrenal contributions. Best Practice & Research Clinical Obstetrics & Gynaecology, 37, 80-97.
Bouchoucha, M., Uzzan, B., & Cohen, R. (2011). Metformin and digestive disorders. Diabetes & metabolism, 37(2), 90-96.
Bozdag, G. et al. (2016). The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Human reproduction, 31(12), 2841-2855.
Brum, D. G. et al. (2014). Suplementação e uso terapêutico de vitamina D nos pacientes com esclerose múltipla: Consenso do Departamento Científico de Neuroimunologia da Academnia Brasileira de Neurologia. Arquivos de Neuri-Psiquiatria, 72, 152- 156.
Carmina, E. M. D., & Lobo, R. A. M. D. (2004). Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome. Revista. 661-665.
Carvalho, B. R. (2018). Particularidades no manejo da infertilidade. In: Síndrome dos ovários policísticos. São Paulo: Federação Brasileira das Associações de Ginecologia e Obstetrícia (Febrasgo), 8. 88-103.
Cooney, L. G. (2018). Dokras, Beyond fertility: polycystic ovary syndrome and long- term health, revista. 110, 794-809.
Cozzolino, S. M. F., Morais, C. C., & Cominetti, C. (2016). Biodisponibilidade de Nutrientes. (5a ed.) Manole, 11, 341-368
De Carvalho, B. R. (2019). Síndrome dos ovários policísticos: particularidades no manejo da infertilidade. FEMINA, 47, 9, 518-45.
Duarte, J. A. (2011). Metformina e o seu papel no tratamento da infertilidade em mulheres com Síndrome do Ovário Poliquístico. Universidade do Porto. Porto, 23.
Fang, F., et al. (2017). Effect of vitamin D supplementation on polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials. Complementary therapies in clinical practice, 26, 53-60.
Fauser, B. C. J. M., et al. (2012). Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertility and Sterility, 97(1), 28-38
Ferriani, R. A., Vieira, C. S., Brito, L. G. O. (2015). Rotinas em Ginecologia. Atheneu,
Firouzabadi, R. D., et al. (2012). Therapeutic effects of calcium & vitamin D supplementation in women with PCOS. Complementary Therapies in Clinical Practice, 2(18), 85-88,
Freitas, L. A. R. D., et al. (2017). Uso de metformina em mulheres obesas com Síndrome do Ovário Policístico. Revista Ciências Médicas, Campinas, 25(2), 87-97.
Graham, G. G., et al. (2011). Clinical pharmacokinetics of metformin. Clinical pharmacokinetics, 50(2), 81-98.
Holm, N. S. L., et al. (2012). The prevalence of endometrial hyperplasia and endometrial cancer in women with polycystic ovary syndrome or hyperandrogenism. Acta Obstet Gynecol Scand, 10(91), 1173-1176,
Jomaa, C. (2019). Vitamina D na Sindrome dos Ovários Policisticos (SOP): Revisão de Literatura, São Paulo, 30.
Kuçukazman, M., et al. (2014). The association of vitamin D deficiency with non-alcoholic fatty liver disease. Clinics. 69, 542-546.
Krul-Poel, Y. H. M., et al. (2018). Vitamin D and metabolic disturbances in polycystic ovary syndrome (PCOS): A cross-sectional study. PloS ONE. 13(12), e0204748.
Legro, R. S., Castracane, V. D., & Kauffman, R. P. (2004). Detecting Insulin Resistance in Polycystic Ovary Syndrome: Purposes and Pitfalls. Obstetrical and Gynecological Survey, 59(2), 141-154.
Lima, L. G., & Ferreira, L. A. (2017). A Metformina Na Indução Da Ovulação Em Mulheres Com Síndrome Dos Ovários Policísticos. Visão Acadêmica, Curitiba, 18(2), 1518-8361.
Maciel, D. G., & De Abreu Reis, M. J. (2017). Frequência de hipovitaminose D em mulheres adultas. Journal of the Health Sciences Institute, 35(4), 257-260.
Macut, D., et al. (2017). Insulin and the polycystic ovary syndrome. Diabetes Research and Clinical Practice, 130, 163-170.
Marcondes, J. A. M., Barcellos, C. R. G., & Rocha, M. P. (2011). Dificuldades e armadilhas no diagnóstico da síndrome dos ovários policísticos. Arq Bras Endocrinol Metab., São Paulo, 1(55), 6-15.
Menichini, D., Facchinetti. (2019). Effects of vitamin D supplementation in women with polycystic ovary syndrome: a review. Gynecological Endocrinology, 1-5.
Mosca, L., et al. (2011). Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update. Circulation, 123(11), 1243–1262.
Motta, E. L. A. D., Domingues, T., & Júnior, J. M. S. (2012). O uso de sensibilizadores de insulina no tratamento de infertilidade em pacientes com síndrome dos ovários policísticos (SOP). Revista Brasileira de Ginecologia e Obstetria, São Paulo.
Neto, E. M. R., et al. (2015). Metformina: Uma Revisão Da Literatura. Saúde e Pesquisa, Maringá, 8(2), 355-362.
Pal, L., et al. (2012). Therapeutic implications of vitamin D and calcium in overweight women with polycystic ovary syndrome. Gynecol Endocrinol, 12(28), 965-968.
Pereira, J. M., De Oliveira Silva, V., & Cavalcanti, D. S. P. (2015). Síndrome do ovário policístico: terapia medicamentosa com metformina e anticoncepcionais orais. Saúde & Ciência Em Ação, 1(1), 26-42.
Pontes, A. P. E. A. (2012). Resistência à insulina em mulheres com síndrome dos ovários policísticos: relação com as variáveis antropométricas e bioquímicas, 74- 798. https://doi.org/10.1590/S0100-72032012000200006.
Raja-Khan, N. et al. (2014). High-dose vitamin D supplementation and measures of insulin sensitivity in polycystic ovary syndrome: a randomized, controlled pilot trial. Fertil Steri, 6(101), 1740–1746.
Razavi, M., et al. (2016). The Effects of Vitamin D-K-Calcium Co-Supplementation on Endocrine, Inflammation, and Oxidative Stress Biomarkers in Vitamin D-Deficient Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo- Controlled Trial. Horm Metab Res, 7(48), 446-451.
Ribas Filho, D., De Almeida, C. A N., & De Oliveira Filho, A. E. (2019). Posicionamento atual sobre vitamina D na prática clínica: Posicionamento da Associação Brasileira de Nutrologia (Abran). International Journal of Nutrology, 12(03), 082-096.
Rodrigues, B. B., et al. (2019). Vitamina D na regulação do organismo humano e implicações de sua deficiência corporal. Brazilian Journal of Health Review, Curitiba, 2(5), 4682-4692.
Romano, L. G. M. et al. (2011). Anormalidades metabólicas em mulheres com síndrome dos ovários policísticos: obesas e não obesas, São Paulo, 310-316.
Sahmaya, S., et al. (2018). Serum AMH levels and insulin resistance in women with PCOS, 159-164, ISSN https://doi.org/10.1016/j.ejogrb.2018.03.007.
Sales, L. S., et al. (2018). Vitamin D supplementation in Polycystic Ovarian Syndrome. SciTz Nutr Food Sci. 3(1)
Santos, T. S., et al. (2019). Aspectos Nutricionais E Manejo Alimentar Em Mulheres Com Síndrome Dos Ovários Policísticos, Teresina, 649- 670.
Silva, R. D. C., Pardini, D. P., & Kater, E. (2066). Síndrome dos ovários policísticos, síndrome metabólica, risco cardiovascular e o papel dos agentes sensibilizadores da insulina. Arq Bras Endocrinol Metab, São Paulo, 50(2), 281-290.
Soares, D. O. Q., et al. Indicação De Metformina Em Pacientes Anovulatórias. Brazilian Journal of Surgery and Clinical Research, 14(1), 38-42,
Souza, B. F., & Dytz, P. (2020). Intervenções não farmacológicas no tratamento da síndrome dos ovários policísticos: uma revisão de literatura (Bacharelado em Nutrição) Uniceub, Brasília.
Spritzer, P. M. (2014). Polycystic ovary syndrome: reviewing, São Paulo, 182-187, ISSN http://dx.doi.org/10.1590/0004-2730000003051.
The Androgen Excess and Pcos Society. (2009). The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertility and Sterility, 91(2), 456-488.
The Rotterdam Eshre/Asrm-Sponsored Pcos Consensus Workshop Group. (2004). Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction, 19(1), 41-47.
The Thessaloniki Eshre/Asrm-Sponsored Pcos Consensus Workshop Group. (2008). Consensus on infertility treatment related to polycystic. Human Reproduction, 23(3), 462-477.
Thomson, R. L., Spedding, S., & Buckley, J. D. (2012). Vitamin D in the aetiology and management of polycystic ovary syndrome. Clinical Endocrinology, 3(77), 343- 350.
Traub, M. L. (2011). Assessing and Treating Insulin Resistance. World Journal Diabetes, 2(3), 33-40.
Vale, V. A. L. D., et al. (2021). O Uso de Metformina no Tratamento da Síndrome dos Ovários Policísticos. Brazilian Journal of Health Review, Curitiba, 4(2), 4426-4436.
Wehr, E., Pieber, T. R., Obermayer-Pietsch, B. (2011). Effect of vitamin D3 treatment on glucose metabolism and menstrual frequency in polycystic ovary syndrome women: a pilot study. J. Endocrinol. Invest., 10(34), 757-763.
Yang, P.-K., et al. (2018). Changes in peripheral mitochondrial DNA copy number in metformin-treated women with polycystic ovary syndrome: a longitudinal study. J Clin Endocrinol Metab, 3(103), 890–899.
Yarak, S., et al. (2005). Hiperandrogenismo e pele: síndrome do ovário policístico e resistência periférica à insulina, 395-409.
Yau, T. T. L., et al. (2017). Polycystic ovary syndrome: a common reproductive syndrome with long-term metabolic consequences, 622-634.
Zahra, M., et al. (2016), Effects of Metformin on Endocrine and Metabolic Parameters in Patients with Polycystic Ovary Syndrome. Horm Metab Res, 2(49), 103-108.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Larissa Adriane dos Santos Moss ; Pollyanna Lourdes Felix Munarim Hauser Gonçalves; Francisca Marta Nascimento de Oliveira Freitas; José Carlos de Sales Ferreira
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
